Placebo effects: clinical aspects and neurobiology - PubMed (original) (raw)

Review

. 2008 Nov;131(Pt 11):2812-23.

doi: 10.1093/brain/awn116. Epub 2008 Jun 21.

Affiliations

Review

Placebo effects: clinical aspects and neurobiology

Barry S Oken. Brain. 2008 Nov.

Abstract

Placebo effects are beneficial health outcomes not related to the relatively direct biological effects of an intervention and can be elicited by an agent that, by itself, is inert. Understanding these placebo effects will help to improve clinical trial design, especially for interventions such as surgery, CNS-active drugs and behavioural interventions which are often non-blinded. A literature review was performed to retrieve articles discussing placebo implications of clinical trials, the neurobiology of placebo effects and the implications of placebo effect for several disorders of neurological relevance. Recent research in placebo analgesia and other conditions has demonstrated that several neurotransmitter systems, such as opiate and dopamine, are involved with the placebo effect. Brain regions including anterior cingulate cortex, dorsolateral prefrontal cortex and basal ganglia have been activated following administration of placebo. A patient's expectancy of improvement may influence outcomes as much as some active interventions and this effect may be greater for novel interventions and for procedures. Maximizing this expectancy effect is important for clinicians to optimize the health of their patient. There have been many relatively acute placebo studies that are now being extended into clinically relevant models of placebo effect.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Theoretical model of issues impacting development of expectancy and how brain outputs may produce a placebo effect.

Similar articles

Cited by

References

    1. Ader R. The placebo effect: if it's all your head, does that mean you only think you feel better? Adv Mind Body Med. 2000;16:7–11. - PubMed
    1. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav Immun. 2002;17:S51–7. - PubMed
    1. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science. 1982;215:1534–6. - PubMed
    1. Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001.
    1. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19:484–94. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources